Evidence map›Paper›PMID 35438548›Full record

ArticleTissue engineering. Part C, Methods2022

Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells.

Robert C H Gresham, Devanshi Kumar, Jonathan Copp, Mark A Lee, J Kent Leach

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Robert C H GreshamDepartment of Orthopedic Surgery, School of Medicine, University of California Davis Health, Sacramento, California, USA.
Devanshi KumarDepartment of Biomedical Engineering, University of California, Davis, Davis, California, USA.
Jonathan CoppDepartment of Orthopedic Surgery, School of Medicine, University of California Davis Health, Sacramento, California, USA.
Mark A LeeDepartment of Orthopedic Surgery, School of Medicine, University of California Davis Health, Sacramento, California, USA.
J Kent LeachDepartment of Orthopedic Surgery, School of Medicine, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-1673-3335
University of California, Davis · USForrest General Hospital · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Identifying the superior ossification pathway for tissue engineered approaches to long bone repairR01AR079211 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEACH, J. KENT · 2021 to 2025
$1.9M
NCI NIH HHS P30 CA093373NIAMS NIH HHS R01 AR079211
6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) from older donors have limited potential for bone tissue formation compared with cells from younger donors, and cellular senescence has been postulated as an underlying cause. There is a critical need for methods to induce premature senescence to study this phenomenon efficiently and reproducibly. However, the field lacks consensus on the appropriate method to induce and characterize senescence. Moreover, we have a limited understanding of the effects of commonly used induction methods on senescent phenotype. To address this significant challenge, we assessed the effect of replicative, hydrogen peroxide, etoposide, and irradiation-induced senescence on human MSCs using a battery of senescent cell characteristics. All methods arrested proliferation and resulted in increased cell spreading compared with low passage controls. Etoposide and irradiation increased expression of senescence-related genes in MSCs at early time points, proinflammatory cytokine secretion, DNA damage, and production of senescence-associated β-galactosidase. We then evaluated the effect of fisetin, a flavonoid and candidate senolytic agent, to clear senescent cells and promote osteogenic differentiation of MSCs entrapped in gelatin methacryloyl (GelMA) hydrogels

Indexed as

Mesenchymal Stem CellsOsteogenesisCell DifferentiationCell ProliferationCells, CulturedCellular SenescenceEtoposideGelatinMethacrylatesSenotherapeuticsEtoposideGelatingelatin methacryloylMethacrylatesSenotherapeuticshydrogelMSCsosteogenesissenescencesenolytic agent

Identifiers

PMID35438548
PMCPMC9247679
OpenAlexW4224262016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.